My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 118

    1.

    Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes.

    Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, Hainault I, Vexiau P, Mauvais-Jarvis F, Calvo F, Gautier JF.

    Diabetes Care. 2008 Dec;31(12):2332-7. Epub 2008 Sep 22.PMID: 18809633 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?

    Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA.

    Diabetes. 1999 Aug;48(8):1572-8.PMID: 10426375 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Assessment of hepatic insulin action in obese type 2 diabetic patients.

    Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H.

    Diabetes. 2001 Jun;50(6):1363-70.PMID: 11375337 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.

    Meneilly GS, Elliott T.

    Diabetes Care. 1999 Jan;22(1):112-8.PMID: 10333911 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

    Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.

    Diabetes. 2005 Nov;54(11):3148-53.PMID: 16249438 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91.PMID: 12050251 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy.

    Yki-Järvinen H, Koivisto VA.

    J Clin Endocrinol Metab. 1984 Sep;59(3):371-8.PMID: 6430945 [PubMed - indexed for MEDLINE]Related articles

    9.

    Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

    Gastroenterology. 2008 Jul;135(1):122-30. Epub 2008 Mar 21.PMID: 18474251 [PubMed - indexed for MEDLINE]Related articles

    10.

    Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation.

    Båvenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S.

    J Clin Endocrinol Metab. 2003 Jan;88(1):82-7. Erratum in: J Clin Endocrinol Metab. 2003 May;88(5):2036. PMID: 12519834 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

    Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43.PMID: 12424102 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

    Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

    Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin action and skeletal muscle blood flow in patients with Type 1 diabetes and microalbuminuria.

    Wiggam MI, Hunter SJ, Ennis CN, Sheridan B, Atkinson AB, Bell PM.

    Diabetes Res Clin Pract. 2001 Aug;53(2):73-83.PMID: 11403855 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.

    Cusi K, Cukier S, DeFronzo RA, Torres M, Puchulu FM, Redondo JC.

    J Clin Endocrinol Metab. 2001 Mar;86(3):1410-7.PMID: 11238540 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.

    Yki-Järvinen H, Taskinen MR, Kiviluoto T, Hilden H, Helve E, Koivisto VA, Nikkilä EA.

    J Clin Endocrinol Metab. 1984 Dec;59(6):1183-92.PMID: 6490795 [PubMed - indexed for MEDLINE]Related articles

    18.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Bromocriptine: a novel approach to the treatment of type 2 diabetes.

    Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

    Diabetes Care. 2000 Aug;23(8):1154-61.PMID: 10937514 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [The relation between fasting plasma glucose concentrations and insulin resistance]

    Li L, Wang GX, Li P, Shang XJ, Liu C, Wang YJ, Yue GY.

    Zhonghua Nei Ke Za Zhi. 2005 Oct;44(10):755-8. Chinese. PMID: 16255885 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity